North Carolina Incorrectly Claimed Enhanced Federal Reimbursement for Some Medicaid Services That Were Not Family Planning
Effects of the Prospective Payment System on Access to Skilled Nursing Facilities for Patients with End-Stage Renal Disease
North Carolina Incorrectly Claimed Enhanced Federal Reimbursement for Some Medicaid Waiver Services That Were Not Family Planning
Medicare Reimbursement of End Stage Renal Disease Drugs
Virginia Commonwealth University Medical Center Incorrectly Billed Medicare for the Biological Drug Myozyme
External Quality Review of Dialysis Facilities Two Promising Approaches
Indiana Reduced Medicaid Costs for Home Blood-Glucose Test Strips by Approximately 50 Percent Using Manufacturer Rebates
External Quality Review of Dialysis Facilities A Call For Greater Accountability
AdminaStar Federal, Inc., Claimed Some Unallowable Supplemental Executive Retirement Plan Costs for Medicare Reimbursement for Fiscal Years 2004 Through 2006
Problems Pervade the Renal Beneficiary and Utilization System
Audit of Palmetto GBA's Railroad Retirement Board Final Administrative Cost Proposals for Fiscal Years 2007 and 2008
Clinical Performance Measures for Dialysis Facilities Lessons Learned by the Major Dialysis Corporations and Implications for Medicare Supplemental Report # 2
401(k) Costs Claimed by Blue Cross Blue Shield of Tennessee for Fiscal Years 2005 Through 2009 Were Reasonable and Allowable
Retirement Accumulation Program Costs Claimed by Blue Cross Blue Shield of Tennessee for Fiscal Years 2008 and 2009 Were Reasonable and Allowable
Clinical Performance Measures for Dialysis Facilities
Review of Medicare Payments Exceeding Charges for Outpatient Services Processed by Wisconsin Physicians Service Insurance Corporation in Jurisdiction 5 for the Period January 1, 2006, Through June 30, 2009
Maine Did Not Always Make Correct Medicaid Claim Adjustments
Home Dialysis Payment Vulnerabilities
Pennsylvania Claimed Medicaid Administrative Costs for Provider Training Under Its Restraint Reduction Initiative
AVAILABILITY OF QUALITY OF CARE DATA IN THE MEDICARE END STAGE RENAL DISEASE PROGRAM